Results 201 to 210 of about 46,429 (250)

Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial. [PDF]

open access: yesJ Immunother Cancer
Carbone DP   +25 more
europepmc   +1 more source

Gender, race and parenthood impact academic productivity during the COVID-19 pandemic: from survey to action

open access: yes, 2020
Staniscuaski F   +16 more
europepmc   +1 more source

Use of Different Anti-PD-1 Checkpoint Combination Strategies for First-Line Advanced NSCLC Treatment-The Experience of Ion Chiricuță Oncology Institute. [PDF]

open access: yesCancers (Basel)
Preda AC   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy